Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

12.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
12.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Cu(II)-complex loaded Eudragit® nanoparticles: design, synthesis, characterization, and enhanced antitumor activity against triple-negative breast cancer.

International journal of pharmaceutics·2026
Same author

In Vitro and In Vivo Effects of a Copper(II)-Hydrazone Complex Against Human Osteosarcoma.

Pharmaceutics·2026
Same author

Synthesis, crystal structure, spectroscopic characterization, theoretical studies and cytotoxicity assays of novel two acylhydrazones and its Cu(II) complexes.

Journal of inorganic biochemistry·2026
Same author

Exploring the Anticancer Properties and Mode of Action of Copper(II)-Furan Acylhydrazone on Human Triple Negative Breast Cancer Cells.

ChemMedChem·2026
Same author

Structural influences on the oxidation and anticancer activities of dicopper(II) complexes containing different selenium and sulfur ligands.

Dalton transactions (Cambridge, England : 2003)·2025
Same author

Advances in copper complexes in cancer treatment.

Drug discovery today·2025

Related Experiment Video

Updated: Jun 20, 2025

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

57.6K

Metallocompounds as anticancer agents against osteosarcoma.

Lucía Santa Maria de la Parra1, Lucía M Balsa1, Ignacio E León2

  • 1CEQUINOR (UNLP, CCT-CONICET La Plata, asociado a CIC), Departamento de Química, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, Blvd. 120 N° 1465, La Plata 1900, Argentina.

Drug Discovery Today
|July 17, 2024
PubMed
Summary

Metal-based compounds show promise for treating bone cancer (osteosarcoma). This review explores their chemistry, antitumor properties, and mechanisms of action in preclinical and clinical models.

Keywords:
Metallocompoundsbone cancermechanism of actionosteosarcoma

More Related Videos

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

12.8K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K

Related Experiment Videos

Last Updated: Jun 20, 2025

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

57.6K
Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

12.8K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.2K

Area of Science:

  • Medicinal Chemistry
  • Oncology
  • Materials Science

Background:

  • Osteosarcoma (OS) is an aggressive bone cancer affecting young individuals, with high metastasis rates and mortality.
  • Current treatments for OS have limitations, necessitating the development of novel therapeutic strategies.

Purpose of the Study:

  • To review the chemistry and antitumor properties of metal-based compounds for osteosarcoma treatment.
  • To analyze structure-activity relationships and molecular targets of these compounds.
  • To elucidate the mechanisms of action underlying their anticancer effects.

Main Methods:

  • Literature review of preclinical (in vitro, in vivo) and clinical studies on metallocompounds in OS models.
  • Analysis of chemical structures and their correlation with biological activity.
  • Investigation of molecular targets and action mechanisms.

Main Results:

  • Metal-based compounds exhibit significant preclinical and clinical antitumor activity against osteosarcoma.
  • Specific structural features of metallocompounds are linked to their efficacy.
  • Various molecular targets and pathways are implicated in their mechanism of action.

Conclusions:

  • Metallocompounds represent a promising class of agents for osteosarcoma therapy.
  • Further research into structure-activity relationships and mechanisms can optimize their clinical application.
  • Targeted development of metal-based drugs could improve outcomes for osteosarcoma patients.